Research Groups
Key research question: The research focus of i-Target is to pioneer new strategies in the three pillars of cancer immunotherapy: cellular therapy, antibody therapy and immunomodulatory therapy.
Research area 1: Targeted cellular therapy
-
Projects A, B, C
Immunopharmacology Group, Division of Clinical Pharmacology, Department of Internal Medicine IV, Klinikum der Universität München
Head: Prof. Dr. Sebastian Kobold and Prof. Dr. Stefan Endres
-
Project D
Department of Internal Medicine III, Klinikum der Universität München
Heads: Prof. Dr. Marion Subklewe
Research area 2: Targeted antibody therapy
-
Project E
Gene Center and Department of Biochemistry of the Ludwig-Maximilians Universität München
Head: Prof. Dr. rer. nat. Karl-Peter Hopfner
Contact: hopfner(at)genzentrum.lmu.de
-
Project F
Dr. von Hauner Children’s Hospital, Klinikum der Universität München
Head: Prof. Dr. Christoph Klein
-
Project G
Department of Internal Medicine V, Friedrich-Alexander Universität Erlangen-Nürnberg
Heads: Prof. Dr. Andreas Mackensen and Prof. Dr. Dimitrios Mougiakakos
Research area 3: Targeted immunomodulatory therapy
-
Project H
Department of Internal Medicine V, Friedrich-Alexander Universität Erlangen-Nürnberg
Heads: Prof. Dr. Andreas Mackensen and Prof. Dr. Dimitrios Mougiakakos
-
Project I
Molecular Oncology Group, Department of Radiotherapy and Radiation Oncology, Klinikum der Universität München
Head: Prof. Dr. rer. nat. Kirsten Lauber
-
Project J, K
Molecular Immunology Group, Institute for Clinical Chemistry and Pathobiochemistry, Technische Universität München
Head: Prof. Dr. Jürgen Ruland
Contact: jruland(at)lrz.tum.de
-
Project L
Cancer Vaccine Lab, Division of Clinical Pharmacology, Department of Internal Medicine IV, Klinikum der Universität München
Head: Prof. Dr. Maximilian Schnurr and Dr. Lars König
Contact: Max.Schnurr(at)med.uni-muenchen.de